Santosh J. Vetticaden

2012 - Mast Therapeutics

In 2012, Santosh J. Vetticaden earned a total compensation of $631.5K as Chief Medical Officer and Senior Vice President at Mast Therapeutics.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$39,603
Option Awards$370,860
Salary$113,750
Other$7,274
Total$631,487

Vetticaden received $370.9K in option awards, accounting for 59% of the total pay in 2012.

Vetticaden also received $100K in bonus, $39.6K in non-equity incentive plan, $113.8K in salary and $7.3K in other compensation.

Rankings

In 2012, Santosh J. Vetticaden's compensation ranked 7,938th out of 11,487 executives tracked by ExecPay. In other words, Vetticaden earned more than 30.9% of executives.

ClassificationRankingPercentile
All
7,938
out of 11,487
31st
Division
Manufacturing
2,866
out of 4,253
33rd
Major group
Chemicals And Allied Products
751
out of 1,198
37th
Industry group
Drugs
534
out of 920
42nd
Industry
Pharmaceutical Preparations
420
out of 700
40th
Source: SEC filing on April 29, 2014.

Vetticaden's colleagues

We found two more compensation records of executives who worked with Santosh J. Vetticaden at Mast Therapeutics in 2012.

2012

Brian Culley

Mast Therapeutics

Chief Executive Officer

2012

Patrick Keran

Mast Therapeutics

Chief Operating Officer

News

In-depth

You may also like